摘要
临床上将射血分数保留的心力衰竭(HFpEF)定义为伴有心力衰竭症状和体征且左室射血分数≥50%的一种心力衰竭类型,表现为HFpEF相关的心脏结构/功能的异常,如左心室肥大、左心房扩大和舒张功能障碍,且往往合并症多,是由多种致病因素共同导致的结果。尽管目前对HFpEF的发病机制认识仍不足,但是存在共同的致病通路,最终导致该疾病的发生发展,这主要与代谢重塑有关。现对代谢重塑在HFpEF中分子机制的研究进展综述如下。
In clinical practice,heart failure with preserved ejection fraction(HFpEF)is defined as a type of heart failure with accompanying symptoms and signs of heart failure and left ventricular ejection fraction≥50%.It is characterized by abnormalities in heart structure/function related to HFpEF,such as left ventricular hypertrophy,left atrial enlargement and diastolic dysfunction,often with multiple comorbidities.It is the result of multiple pathogenic factors working together.At present,the understanding of the pathogenesis of HFpEF is still insufficient,but there are still common pathogenic pathways that ultimately lead to the occurrence and development of the disease.This is mainly related to metabolic remodeling.The research progress on the molecular mechanism of metabolic remodeling in HFpEF is summarized as follows.
作者
刘丰齐
王晓彦
LIU Fengqi;WANG Xiaoyan(Department of Cardiology,Affiliated Hospital of Jiangnan University,Wuxi 214000,Jiangsu,China)
出处
《心血管病学进展》
CAS
2024年第7期612-616,共5页
Advances in Cardiovascular Diseases
基金
江苏省卫健委A类重大立项(ZDA2020023)。
关键词
射血分数保留的心力衰竭
代谢重塑
代谢性炎症
Heart failure with preserved ejection fraction
Metabolic remodeling
Metabolic inflammation